Streamlined solutions for clinical trials
The Linus Health platform incorporates distinct tools for eligibility, phenotyping, safety, and clinically meaningful outcomes.
End-to-end clinical trial platform
With over 160,000 tests administered globally, our suite of precision digital assessments, featuring integrated electronic Clinical Outcome Assessment (eCOA) solutions, is a trusted tool for optimizing clinical trials.
-
Functional
assessments -
Mood & anxiety
disorder screening -
Cognitive
assessments -
Motor
assessments -
Hearing
assessments
Enabling researchers to meet increasing clinical trial and study demands
-
Confirm efficacy
Empower your selection process and enhance the standard of care with an all-in-one digital platform. Our validated, well-established cognitive assessments utilize process-based analytics to offer an objective measure of cognition, free from administrator bias. Additionally, embedded sensitive measures swiftly generate rich and sensitive output.
-
Monitor meaningful benefits
Regulatory bodies require neurodegenerative disease interventions to show a clinically meaningful effect. Linus Health’s approach evaluates treatment benefits by capturing each person’s voice individually, ensuring functional changes are tangible and personally meaningful, building a stronger foundation for clinical efficacy.
-
Broaden reach
Accessible digital cognitive assessments broaden study populations to secure a proper balance for each study. Through the use of widely available technology, the platform increases diversity and reduces cultural disparities with multilingual and multinational support – leading to more comprehensive and inclusive studies that embody true health equity.
A library of next-generation digital assessment tools
Linus Health digital assessments typically take under three minutes and can be administered by any clinical staff, no skilled technicians required. Unlike others, we capture thousands of process metrics through embedded sensor arrays, providing deeper brain function insights. With automated scheduling, we reduce operational costs and support prescreening, safety, and efficacy outcomes.
-
Drawing-based
Evaluates cognitive and motor skills through drawing tasks.
iPad based assessments using an Apple Pencil evaluate cognitive and motor skills through unique, well-validated tools like DCTclock™ and DCR™, plus digital versions of Digit Symbol, Trails, and Spiral Tracing. Machine-learning algorithms also extract sensitive process-based performance metrics.
-
Voice-based
Analyzes voice to assess cognitive and neurological function.
Evaluate verbal abilities with tasks testing language fluency, executive function, and verbal memory. Beyond traditional metrics, advanced signal and natural language processing extract novel acoustic, semantic, and time-based process metrics for deeper insights.
-
Eye tracking
Monitors eye movements to assess cognition.
Track participants' eye gaze to assess cognitive and visual processing with tools like Passive Memory Assessment (VisMET) and Fototest. We leverage state-of-the-art machine learning algorithms and advanced computing solutions to evaluate cognition by tracking gaze.
-
Function
Evaluates daily living skills and physical capabilities.
Assess functional independence in basic and instrumental activities of daily living such as shopping, cooking, managing finances, self-care, and orientation through the use of FAST, iADL, ADL, and Orientation-6 questionnaires.
-
Meaningful treatment benefits
Measures real-world impact and effectiveness of treatments.
Capture and monitor change in personally meaningful treatment outcomes with the novel electronic Person Specific Outcome Measure (ePSOM™). ePSOM prompts individuals to use their own words to describe what aspects of brain health matter to them the most and quantifies their changes over time.
-
Digital speech and hearing
Analyzes hearing abilities using digital tools.
Assess hearing abilities using our digital Speech Hearing Screener (dSHS) to identify concerns with functionally meaningful speech, hearing or a discrimination that may affect test performance and comprehension. Identify hearing impairment as an established risk factor for developing dementia.
-
Mobility
Mobility and gait assessment solutions.
Our Kinesis product line includes solutions to assess gait, balance, mobility and falls risk. The sensor-based products (Kinesis QTUG™, Kinesis Gait™ & Kinesis Balance™) evaluate performance in a range of walking, balance, and mobility tests and can support in-clinic or remote assessment protocols.
-
Mood & anxiety disorders
Identifies and assesses mood and anxiety disorders.
Screen for mental health conditions including depression, anxiety, and related disorders using GDS, PHQ, and GAD-7 questionnaires.